You are here:
Home /
Briefs / Protected: pSivida insert in new trial for posterior uveitis
Protected: pSivida insert in new trial for posterior uveitis
Filed under Briefs · Tagged with Alimera Sciences, Bausch & Lomb, corticosteroid fluocinolone acetonide, diabetic macular edema, DME, Dr. Paul Ashton, Durasert technology system, FAc, Iluvien, posterior uveitis, pSivida, Retisert